Publications
- Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice2011 | First Faculty of Medicine
- New prognostic markers of chronic lymphocytic leukemia (CLL) in the everyday hematological practice : an analysis of data from four hematology departments2010 | First Faculty of Medicine
- Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia2010 | First Faculty of Medicine
- Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization2009 | First Faculty of Medicine
- Telomere length evaluation in patients with untreated B-chronic lymphotic leukemia : correlation with other molecular, cytogenetic and immunophenotypic featuresPublication without faculty affiliation
- De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors2024 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen
- Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group2021 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Léčebné postupy v hematologii 2020. Doporučení České hematologické společnosti České lékařské společnosti Jana Evangelisty Purkyně2020 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine
- Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...